Literature DB >> 1969604

The Felty syndrome: a case-matched study of clinical manifestations and outcome, serologic features, and immunogenetic associations.

G Campion1, P J Maddison, N Goulding, I James, M J Ahern, I Watt, D Sansom.   

Abstract

Thirty-two patients with the Felty syndrome, defined by the presence of rheumatoid arthritis, splenomegaly, and neutropenia, have been studied in comparison with 32 patients with rheumatoid arthritis matched for age, sex, and disease duration, and 9 patients with rheumatoid arthritis and idiopathic neutropenia. Patients with the Felty syndrome had severe destructive arthritis, which progressed during follow-up despite little evidence of objective synovitis, and a higher frequency of extra-articular manifestations, including vasculitis. Bacterial infection tended to occur in patients with the lowest neutrophil count but continued to occur in some despite normalization of the WBC. Prognosis was poor and 8 deaths occurred, predominantly from sepsis. Serologic features were prominent. High titers of IgG rheumatoid factor and circulating immune complexes characterized patients with persistent neutropenia. A family history of rheumatoid arthritis was more common in patients with the Felty syndrome. The association with HLA DR4 was very strong; in addition there was an increased frequency of the DQw3 variant, 3b, suggesting that HLA Class II genes in linkage with DR4 may contribute to disease expression.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1969604

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  20 in total

1.  GM-CSF versus G-CSF in the treatment of infectious complication in Felty's syndrome--a case report.

Authors:  U Kaiser; M Klausmann; G Richter; K H Pflüger
Journal:  Ann Hematol       Date:  1992-04       Impact factor: 3.673

2.  An unusual association of Felty syndrome and TCR gamma delta lymphocytosis.

Authors:  S J Stanworth; L Green; R S Pumphrey; D R Swinson; M Bhavnani
Journal:  J Clin Pathol       Date:  1996-04       Impact factor: 3.411

3.  G-CSF in Felty's syndrome: correction of neutropenia and effects on cytokine release.

Authors:  R Schots; L A Verbruggen; C Demanet
Journal:  Clin Rheumatol       Date:  1995-01       Impact factor: 2.980

Review 4.  Felty's syndrome without rheumatoid arthritis?

Authors:  Ap Rozin; R Hoffman; T Hayek; A Balbir-Gurman
Journal:  Clin Rheumatol       Date:  2013-01-05       Impact factor: 2.980

Review 5.  Immunodeficiency secondary to anticytokine autoantibodies.

Authors:  Sarah K Browne; Steven M Holland
Journal:  Curr Opin Allergy Clin Immunol       Date:  2010-12

6.  Examination of HLA-DR4 as a severity marker for rheumatoid arthritis in Greek patients.

Authors:  K A Boki; A A Drosos; A G Tzioufas; J S Lanchbury; G S Panayi; H M Moutsopoulos
Journal:  Ann Rheum Dis       Date:  1993-07       Impact factor: 19.103

7.  Felty's syndrome as an initial presentation of rheumatoid arthritis: a case report.

Authors:  Disaya Chavalitdhamrong; Ana Molovic-Kokovic; Andrey Iliev
Journal:  Cases J       Date:  2009-11-18

8.  Autoantibodies against granulocyte-macrophage colony stimulating factor and interleukin-3 are rare in patients with Felty's syndrome.

Authors:  B Hellmich; A Ciaglo; H Schatz; G Coakley
Journal:  Ann Rheum Dis       Date:  2004-07       Impact factor: 19.103

Review 9.  Rheumatoid arthritis in the aged. Incidence and optimal management.

Authors:  G Nesher; T L Moore
Journal:  Drugs Aging       Date:  1993 Nov-Dec       Impact factor: 3.923

10.  HLA heterozygosity contributes to susceptibility to rheumatoid arthritis.

Authors:  P Wordsworth; K D Pile; J D Buckely; J S Lanchbury; B Ollier; M Lathrop; J I Bell
Journal:  Am J Hum Genet       Date:  1992-09       Impact factor: 11.025

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.